BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2855411)

  • 81. [Clinical significance of carcinoembryonic antigen in patients with lung cancer (author's transl)].
    Shirakusa T
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Sep; 27(9):1294-9. PubMed ID: 501174
    [No Abstract]   [Full Text] [Related]  

  • 82. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Ohkura H; Suemasu K
    Cancer; 1986 Apr; 57(7):1318-23. PubMed ID: 3004689
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Alveolar macrophage function is altered in patients with lung cancer.
    Pouniotis DS; Plebanski M; Apostolopoulos V; McDonald CF
    Clin Exp Immunol; 2006 Feb; 143(2):363-72. PubMed ID: 16412062
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Relationship between syndrome types of TCM in lung neoplasm patients and peripheral T lymphocyte subsets, carcino-embryonic antigen].
    Fang CL; Zong WJ; Fan GR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Jul; 15(7):405-7. PubMed ID: 7580060
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Soluble Human Leukocyte Antigen-G in the Bronchoalveolar Lavage of Lung Cancer Patients.
    Montilla D; Pérez M; Borges L; Bianchi G; Cova JA
    Arch Bronconeumol; 2016 Aug; 52(8):420-4. PubMed ID: 27004472
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Correlation of elevated C1q binding activity and carcinoembryonic antigen levels with clinical features and prognosis in bronchogenic carcinoma.
    Dent PB; Louis JA; McCulloch PB; Dunnett CW; Cerottini JC
    Cancer; 1980 Jan; 45(1):130-6. PubMed ID: 6243237
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Diagnostic value of carcinoembryonic antigen in bronchoalveolar lavage fluid of peripheral lung cancer.
    de Diego A; Compte L; Sanchis J; Enguidanos MJ; Marco V
    Chest; 1990 Mar; 97(3):767-8. PubMed ID: 2306989
    [No Abstract]   [Full Text] [Related]  

  • 88. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR; Skinner M; Gibbs AR
    Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The activity of neutrophil myeloperoxidase in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Pietruczuk M; Kemona H; Wołosowicz N; Kiluk S; Głuszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):613-9. PubMed ID: 2465241
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunoperoxidase staining for carcinoembryonic antigen in small cell carcinoma of the lung.
    Sehested M; Hirsch FR; Hou-Jensen K
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1125-31. PubMed ID: 6279407
    [No Abstract]   [Full Text] [Related]  

  • 91. Lack of correlation between carcinoembryonic antigen content of tumor extracts and leukocyte migration reactivity of tumor patients.
    Matzku S; Zöller M; Schulz U; Dietze W; Barth HO; Saeger HD; Price MR
    J Natl Cancer Inst; 1980 Jun; 64(6):1345-8. PubMed ID: 6929372
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Abnormal epithelial cells recovered by bronchoalveolar lavage: are they malignant?
    Biyoudi-Vouenze R; Tazi A; Hance AJ; Chastre J; Basset F; Soler P
    Am Rev Respir Dis; 1990 Sep; 142(3):686-90. PubMed ID: 1697148
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Sialyl Lewis X-i (SLX) in the bronchoalveolar lavage fluid from patients with lung cancer].
    Shimizu S; Suzuki H; Noguchi E
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):815-20. PubMed ID: 1352835
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A comparison of lung cancer antigens.
    Hollinshead AC; Sega E; Stewart TH; Ricci C; Mineo TC
    Tumori; 1975; 61(2):125-8. PubMed ID: 179173
    [No Abstract]   [Full Text] [Related]  

  • 95. [Local secretory immunity and its significance in the diagnosis of cancer and chronic suppurative-inflammatory diseases of the lungs].
    Kochetkova VA; Sokolov VV; Gantsev FG; Varov AS
    Sov Med; 1989; (5):83-6. PubMed ID: 2781385
    [No Abstract]   [Full Text] [Related]  

  • 96. Elevated prostaglandin E2 levels in bronchoalveolar lavage fluid of patients with bronchogenic carcinoma.
    LeFever A; Funahashi A
    Chest; 1990 Dec; 98(6):1397-402. PubMed ID: 2173996
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Concentrations of carcinoembryonic antigen in serum and bronchoalveolar lavage fluid of asthmatic patients with mucoid impaction].
    Maeda Y; Hizawa N; Fukui Y; Nagai K; Kikuchi E; Takahashi D; Harada T; Suko N; Nishimura M
    Nihon Kokyuki Gakkai Zasshi; 2004 Dec; 42(12):988-93. PubMed ID: 15678904
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Immunoglobulin and lysozyme levels in bronchoalveolar lavage fluid from patients with acute pneumonia in acute leukemia and bronchogenic carcinoma of the lung].
    Ivashkin VT; Iakovlev VN; Borzenkov AS; Piasik MV
    Klin Med (Mosk); 1990 Jun; 68(6):69-73. PubMed ID: 2214643
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Clinical evaluation of CEA and PHA skin reaction in lung cancer (author's transl)].
    Igusa H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Oct; 16(10):765-73. PubMed ID: 723022
    [No Abstract]   [Full Text] [Related]  

  • 100. Carcinoembryonic antigen in sputum.
    Tanno Y; Nishioka K; Takishima T
    Tohoku J Exp Med; 1982 May; 137(1):111-2. PubMed ID: 7101283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.